Ih‐Jen Su

11.9k total citations · 3 hit papers
187 papers, 9.3k citations indexed

About

Ih‐Jen Su is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, Ih‐Jen Su has authored 187 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Epidemiology, 54 papers in Oncology and 49 papers in Infectious Diseases. Recurrent topics in Ih‐Jen Su's work include Viral-associated cancers and disorders (44 papers), Hepatitis B Virus Studies (33 papers) and Lymphoma Diagnosis and Treatment (32 papers). Ih‐Jen Su is often cited by papers focused on Viral-associated cancers and disorders (44 papers), Hepatitis B Virus Studies (33 papers) and Lymphoma Diagnosis and Treatment (32 papers). Ih‐Jen Su collaborates with scholars based in Taiwan, United States and Japan. Ih‐Jen Su's co-authors include Huan‐Yao Lei, Jen‐Ren Wang, Hui‐Ching Wang, Ann‐Lii Cheng, Ching‐Chuan Liu, Kao‐Jean Huang, Hwei‐Fang Tien, Han‐Chieh Wu, Shigeo Mori and Alfred C. Feller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ih‐Jen Su

185 papers receiving 9.1k citations

Hit Papers

Report of the Workshop on... 1996 2026 2006 2016 1996 2004 2011 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas
    1996 581 citations Elaine S. Jaffe, John K.C. Chan et al. The American Journal of Surgical Pathology profile →
  2. An interferon‐γ‐related cytokine storm in SARS patients
    2004 547 citations Ih‐Jen Su, Huan‐Yao Lei et al. Journal of Medical Virology profile →
  3. Mitochondrial Fission Contributes to Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle
    2011 524 citations Ih‐Jen Su et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ih‐Jen Su 3.2k 2.3k 2.2k 1.9k 1.8k 187 9.3k
M. Ho 2.7k 0.8× 1.5k 0.6× 2.4k 1.1× 1.0k 0.5× 1.3k 0.7× 171 7.3k
Guido Antonelli 2.5k 0.8× 2.3k 1.0× 1.0k 0.5× 519 0.3× 1.4k 0.8× 371 7.4k
Ih‐Jen Su 2.0k 0.6× 1.6k 0.7× 1.0k 0.5× 575 0.3× 563 0.3× 105 5.1k
Eleanor Barnes 5.0k 1.6× 1.3k 0.5× 2.3k 1.1× 1.1k 0.6× 1.6k 0.9× 297 12.0k
Michel Goldman 2.9k 0.9× 1.0k 0.4× 1.6k 0.7× 722 0.4× 9.5k 5.2× 368 16.9k
David W. Alling 3.4k 1.1× 1.8k 0.8× 596 0.3× 376 0.2× 1.7k 1.0× 122 8.5k
Rui Sun 3.0k 0.9× 1.3k 0.6× 3.4k 1.5× 585 0.3× 8.4k 4.6× 266 14.5k
Carlos V. Payá 6.5k 2.1× 2.1k 0.9× 2.8k 1.3× 393 0.2× 2.0k 1.1× 121 11.1k
B. Cribier 2.8k 0.9× 1.0k 0.4× 1.3k 0.6× 1.4k 0.7× 2.2k 1.2× 404 9.3k
Julian Symons 2.9k 0.9× 1.3k 0.5× 593 0.3× 293 0.2× 2.5k 1.4× 102 7.4k

Countries citing papers authored by Ih‐Jen Su

Since Specialization
Citations

This map shows the geographic impact of Ih‐Jen Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ih‐Jen Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ih‐Jen Su more than expected).

Fields of papers citing papers by Ih‐Jen Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ih‐Jen Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ih‐Jen Su. The network helps show where Ih‐Jen Su may publish in the future.

Co-authorship network of co-authors of Ih‐Jen Su

This figure shows the co-authorship network connecting the top 25 collaborators of Ih‐Jen Su. A scholar is included among the top collaborators of Ih‐Jen Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ih‐Jen Su. Ih‐Jen Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Selena Y., Ih‐Jen Su, Joshua P. Earl, et al.. (2024). Characterization of integrated hepatitis B virus DNA harboring pre‐S mutations in hepatocellular carcinoma patients with ground glass hepatocytes. Journal of Medical Virology. 96(1). e29348–e29348.
2.
Lin, Ching‐Hsiung, Shu‐Chen Kuo, Ming‐Chia Hsieh, et al.. (2019). Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: a community-based study in Taiwan. BMJ Open. 9(10). e029948–e029948. 21 indexed citations
3.
Chang, Hong, Hung‐Wen Tsai, Chiao‐Fang Teng, et al.. (2018). Ground glass hepatocytes provide targets for therapy or prevention of hepatitis B virus-related hepatocellular carcinoma. SHILAP Revista de lepidopterología. 5(2). 90–101. 5 indexed citations
4.
Wu, Shan‐Ying, Sheng‐Hui Lan, Xi‐Zhang Lin, et al.. (2016). Autophagy Regulates Human Hepatocellular Carcinoma Tumorigenesis through Selective Degradation of Cyclin D1. 3(10). 2 indexed citations
5.
Dou, Horng-Yunn, et al.. (2014). Prevalence of Mycobacterium tuberculosis strain genotypes in Taiwan reveals a close link to ethnic and population migration. Journal of the Formosan Medical Association. 114(6). 484–488. 16 indexed citations
6.
Chen, Wen‐Chung, Yu‐Hsuan Lai, How‐Ran Guo, et al.. (2013). Interleukin‐17‐producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor. Histopathology. 63(2). 225–233. 106 indexed citations
7.
Chen, Te-Li, Yi‐Tzu Lee, Shu‐Chen Kuo, et al.. (2012). Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan. Journal of Microbiology Immunology and Infection. 46(6). 419–424. 37 indexed citations
8.
Wu, Shang‐Ju, Chien‐Yuan Chen, Ih‐Jen Su, et al.. (2008). Clinical Characteristics and Treatment Response of Hodgkin's Lymphoma in Taiwan. Journal of the Formosan Medical Association. 107(1). 4–12. 3 indexed citations
9.
Chuang, Huai‐Chia, Jong‐Ding Lay, Wen‐Chuan Hsieh, & Ih‐Jen Su. (2007). Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein–Barr virus‐associated T‐cell lymphoma: Nuclear factor‐κB pathway as a potential therapeutic target. Cancer Science. 98(9). 1281–1287. 61 indexed citations
10.
Hsu, Yung-Hsiang, et al.. (2006). Association of NRAMP 1 Gene Polymorphism with Susceptibility to Tuberculosis in Taiwanese Aboriginals. Journal of the Formosan Medical Association. 105(5). 363–369. 38 indexed citations
11.
Chen, Kow‐Tong, Shiing–Jer Twu, Yi-Chun Wu, et al.. (2005). SARS in Taiwan: an overview and lessons learned. International Journal of Infectious Diseases. 9(2). 77–85. 68 indexed citations
12.
Yang, Ya‐Chien, et al.. (2002). Short Communication: Resistance to Tumor Necrosis Factor- α -Induced Apoptosis in Human T-Lymphotropic Virus Type I-Infected T Cell Lines. AIDS Research and Human Retroviruses. 18(3). 207–212. 17 indexed citations
13.
Lu, Cheng‐Chan, Wen‐Chi Chen, Wei‐Jen Yao, et al.. (2001). Prevalence and Significance of Hepatitis B Virus (Hbv) Pre–S Mutants in Serum and Liver At Different Replicative Stages of Chronic Hbv Infection. Hepatology. 33(1). 277–286. 176 indexed citations
14.
Chen, Chi‐Chung, et al.. (2000). Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. Journal of Biomedical Science. 7(6). 523–528. 96 indexed citations
15.
Tsai, Sen‐Tien, et al.. (1997). High prevalence of human papillomavirus types 16 and 18 in middle‐ear carcinomas. International Journal of Cancer. 71(2). 208–212. 1 indexed citations
16.
Ch’ang, Hui-Ju, et al.. (1997). Angioimmunoblastic Lymphadenopathy with Dysproteinemia – Lack of a Prognostic Value of Clear Cell Morphology. Oncology. 54(3). 193–198. 6 indexed citations
17.
Okayama, Akihiko, et al.. (1996). Preferred nucleotide sequence at the integration target site of human T‐cell leukemia virus type I from patients with adult T‐cell leukemia. International Journal of Cancer. 65(1). 20–24. 2 indexed citations
18.
19.
Jaffe, Elaine S., John K.C. Chan, Ih‐Jen Su, et al.. (1996). Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. The American Journal of Surgical Pathology. 20(1). 103–111. 581 indexed citations breakdown →
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Ho Breakdown of academic impact, for papers by Guido Antonelli Breakdown of academic impact, for papers by Ih‐Jen Su Breakdown of academic impact, for papers by Eleanor Barnes Breakdown of academic impact, for papers by Michel Goldman Breakdown of academic impact, for papers by David W. Alling Breakdown of academic impact, for papers by Rui Sun Breakdown of academic impact, for papers by Carlos V. Payá Breakdown of academic impact, for papers by B. Cribier Breakdown of academic impact, for papers by Julian Symons
Rankless by CCL
2026